Loading…
Transgene Biotek (BSE 526139)₹2.52+1.20%Healthcare Service Provider
At the end of the Jun 2026 quarter, Transgene Biotek's shareholders were: promoters 23.61%, public 76.39%. Promoter holding is unchanged on the quarter. 0.00% of promoter shares were pledged. It had 13,822 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 23.61% | 23.61% | 23.61% | 23.61% | 23.61% | 23.61% | 23.61% | 23.61% | 23.61% | 23.61% | 23.61% | 23.61% |
| Public | 76.39% | 76.39% | 76.39% | 76.39% | 76.39% | 76.39% | 76.39% | 76.39% | 76.39% | 76.39% | 76.39% | 76.39% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 11,364 | 12,225 | 12,431 | 12,771 | 12,968 | 13,312 | 13,588 | 13,480 | 13,466 | 13,550 | 13,772 | 13,822 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Dr K Koteswara Rao | Promoter | 21.86% | 0.00 |
| Kollipara Nirmala | Promoter | 1.73% | 0.00 |
| Kollipara Srinivas | Promoter | 0.03% | 0.00 |
Promoters held 23.61% of Transgene Biotek at the end of the Jun 2026 quarter, the same as a year earlier.
No. The Jun 2026 filing shows no pledged promoter shares.
Transgene Biotek had 13,822 shareholders at the end of the Jun 2026 quarter, against 13,480 a year earlier.